Epizyme Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$1.47

+0 (+0%)

At Close: Nov 10, 2022

Currently predicting for Wed, 1 May 2024

EPZM Predictions History

5 years ago
NameNotImportant predicted that EPZM for 2019-04-29 is going $12.50 (-0.87%)

5 years ago
NameNotImportant predicted that EPZM for 2019-04-23 is going $13.01 (2.44%)

5 years ago
PumpTheseNumbers predicted that EPZM for 2019-02-28 is going $13.77 (6.25%)

5 years ago
Clayton.Brewer.102509 predicted that EPZM for 2019-02-28 is going $13.50 (-3.43%)

Rank:

7 years ago
JS predicted that EPZM for 2017-04-26 is going $18.48 (4.70%)

7 years ago
JS predicted that EPZM for 2017-04-19 is going $14.95 (0.34%)

About Epizyme

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in pa... EPZM Profile

Golden Star

Ticker	Date	Change	Price
DHT	Apr 24	1.95%	$11.28
MLI	Apr 19	11.07%	$52.28
LPLA	Apr 19	4.31%	$262.59
DOOR	Apr 18	0.90%	$131.39
PFLT	Apr 18	1.78%	$11.25
LNG	Apr 17	3.12%	$156.81
FCN	Apr 16	2.83%	$207.62
ELV	Apr 16	5.33%	$506.97
AKR	Apr 05	6.47%	$16.53
ITCI	Apr 05	5.64%	$68.44

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Epizyme Stock Predictions

EPZM Predictions History

About Epizyme

Golden Star

Top Fintech Company